Research and Markets: Epilepsy Partnering 2007-2013

Business Wire


Research and Markets has announced the addition of the "Epilepsy Partnering 2007-2013" report to their offering.

The Epilepsy Partnering 2007-2013 provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies .

The report provides an analysis of epilepsy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors epilepsy technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

This data driven report contains over 40 links to online copies of actual epilepsy deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

This data driven report includes:

  • Trends in epilepsy dealmaking in the biopharma industry since 2007
  • Access to summary headline, upfront, milestone and royalty data
  • The leading epilepsy deals by value since 2007

In Epilepsy Partnering 2007-2013, the available deals are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Company A-Z
  • Industry sector
  • Stage of development at signing
  • Deal component type
  • Technology type

Epilepsy Partnering 2007-2013 provides the reader with the following key benefits:

  • In-depth understanding of epilepsy deal trends since 2007
  • Access to summary headline, upfront, milestone and royalty data
  • Comprehensive access to over 40 actual epilepsy deals entered into by the world's biopharma companies since 2007
  • Insight into key deal terms included in contracts, where disclosed
  • Understand the key deal terms companies have agreed in deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Key Topics:

Chapter 1 - Introduction

Chapter 2 - Trends in epilepsy partnering

Chapter 3 - Leading Epilepsy deals

Chapter 4 - Dealmaking directory

Chapter 5 - Partnering resource center

For more information visit Research and Markets

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals
View Comments